Abstract
Impulse control disorders (ICD) have been recognised in Parkinson’s disease (PD) as adverse effects of dopamine replacement therapy, particularly with dopamine agonists. Although virtually all PD patients are treated with dopaminergic drugs, only a minority will develop hyperdopaminergic states, suggesting predisposing and/or protecting factors. The age at onset, the sex and the dose or type of dopaminergic drugs have been identified as clinical predictive factors. Recent genetic studies have investigated associations between ICD and polymorphisms of genes involved in the dopamine metabolism pathway (COMT, DAT), dopamine receptors (DRD1, DRD2, DRD3, DRD4), serotonin receptors and its transporter (HTR2A, 5HTT), and glutamate receptors (GRIN2B). Although validation in larger and independent cohorts is needed, the results from these studies give us some insights into the pathophysiology of hyperdopaminergic states and may be useful, at term, in personalising antiparkinsonian treatment in clinical practice.
Similar content being viewed by others
References
Althaus M, Groen Y, Wijers AA, Mulder LJ, Minderaa RB, Kema IP, Dijck JD, Hartman CA, Hoekstra PJ (2009) Differential effects of 5-HTTLPR and DRD2/ANKK1 polymorphisms on electrocortical measures of error and feedback processing in children. Clin Neurophysiol 120(1):93–107. doi:10.1016/j.clinph.2008.10.012
Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P (2011) Impulsivity and compulsivity in drug-naive patients with Parkinson’s disease. Mov Disord 26(3):464–468. doi:10.1002/mds.23501
Ardouin C, Chereau I, Llorca PM, Lhommee E, Durif F, Pollak P, Krack P (2009) Assessment of hyper- and hypodopaminergic behaviors in Parkinson’s disease. Rev Neurol (Paris) 165(11):845–856. doi:10.1016/j.neurol.2009.06.003
Black DW, Moyer T (1998) Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49(11):1434–1439
Brewer JA, Potenza MN (2008) The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 75(1):63–75. doi:10.1016/j.bcp.2007.06.043
Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Rosenthal RJ, Lesieur HR, Rugle LJ, MacMurray P (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2(1):44–56
Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C, Koh P, Farwell K, Blake H, Dietz G, MacMurray JP, Lesieur HR, Rugle LJ, Rosenthal RJ (2001) The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 60(2):107–116. pii:cge600204
Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56(4):993–998
Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP (2005) Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10(7):686–698. doi:10.1038/sj.mp.4001641
da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V, Kennedy JL (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 23(4):421–433. doi:10.1007/s10899-007-9060-x
Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH (1997) Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking. Mol Psychiatry 2(6):472–477
Eisen SA, Lin N, Lyons MJ, Scherrer JF, Griffith K, True WR, Goldberg J, Tsuang MT (1998) Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 93(9):1375–1384
Eisenegger C, Knoch D, Ebstein RP, Gianotti LR, Sandor PS, Fehr E (2010) Dopamine receptor D4 polymorphism predicts the effect of l-DOPA on gambling behavior. Biol Psychiatry 67(8):702–706. doi:10.1016/j.biopsych.2009.09.021
Floresco SB, Tse MT, Ghods-Sharifi S (2008) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33(8):1966–1979. doi:10.1038/sj.npp.1301565
Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14(1):60–70. doi:10.1038/sj.mp.4002086
Frank MJ, Seeberger LC, O’Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science 306(5703):1940–1943. doi:10.1126/science.1102941
Gelernter J, Kranzler HR, Satel SL, Rao PA (1994) Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11(3):195–200. doi:10.1038/sj.npp.1380106
Gorwood P, Le Strat Y, Ramoz N, Dubertret C, Moalic JM, Simonneau M (2012) Genetics of dopamine receptors and drug addiction. Hum Genet 131(6):803–822. doi:10.1007/s00439-012-1145-7
Grice DE, Leckman JF, Pauls DL, Kurlan R, Kidd KK, Pakstis AJ, Chang FM, Buxbaum JD, Cohen DJ, Gelernter J (1996) Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am J Hum Genet 59(3):644–652
Guo G, Tong Y, Xie CW, Lange LA (2007) Dopamine transporter, gender, and number of sexual partners among young adults. Eur J Hum Genet 15(3):279–287. doi:10.1038/sj.ejhg.5201763
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66(6):2621–2624
Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133–139. doi:10.1016/S0893-133X(99)00099-8
Heitland I, Oosting RS, Baas JM, Massar SA, Kenemans JL, Bocker KB (2012) Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans. Cogn Affect Behav Neurosci. doi:10.3758/s13415-012-0108-8
Hersrud SL, Stoltenberg SF (2009) Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study. Eat Behav 10(2):131–133. doi:10.1016/j.eatbeh.2009.01.003
Holden C (2001) ‘Behavioral’ addictions: do they exist? Science 294(5544):980–982. doi:10.1126/science.294.5544.980
Ibanez A, Blanco C, Perez de Castro I, Fernandez-Piqueras J, Saiz-Ruiz J (2003) Genetics of pathological gambling. J Gambl Stud 19(1):11–22
Juhasz G, Downey D, Hinvest N, Thomas E, Chase D, Toth ZG, Lloyd-Williams K, Mekli K, Platt H, Payton A, Bagdy G, Elliott R, Deakin JF, Anderson IM (2010) Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders. Neuropsychopharmacology 35(5):1109–1119. doi:10.1038/npp.2009.216
Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162(8):1403–1413. doi:10.1176/appi.ajp.162.8.1403
Karkowski LM, Prescott CA, Kendler KS (2000) Multivariate assessment of factors influencing illicit substance use in twins from female–female pairs. Am J Med Genet 96(5):665–670. doi:10.1002/1096-8628(20001009)96:5<665AID-AJMG13>3.0.CO;2-O
Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, Kramer I, Zer-Zion M, Kletz I, Ebstein RP (1997) Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 2(3):251–254
Kreek MJ, Nielsen DA, LaForge KS (2004) Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 5(1):85–108. doi:10.1385/NMM:5:1:085
Kreek MJ, Nielsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8(11):1450–1457. doi:10.1385/NMM:5:1:085
Kuhnen CM, Chiao JY (2009) Genetic determinants of financial risk taking. PLoS ONE 4(2):e4362. doi:10.1371/journal.pone.0004362
LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1(2):121–124
Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease. Mov Disord 24(12):1803–1810. doi:10.1002/mds.22678
Lee JY, Jeon BS, Kim HJ, Park SS (2012) Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson’s disease. Parkinsonism Relat Disord 18(1):76–78. doi:10.1016/j.parkreldis.2011.08.009
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531
Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13):4202–4210
Muramatsu T, Higuchi S (1995) Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211(1):28–32. doi:10.1006/bbrc.1995.1773
Ness V, Arning L, Niesert HE, Stuttgen MC, Epplen JT, Beste C (2011) Variations in the GRIN2B gene are associated with risky decision-making. Neuropharmacology 61(5–6):950–956. doi:10.1016/j.neuropharm.2011.06.023
Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540–545. doi:10.1002/humu.20039
Noble EP (2000) Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 15(2):79–89. doi:10.1016/S0924-9338(00)00208-X
Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J (1997) Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7(5):345–348
Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Montastruc JL, Rascol O (2012) Do Parkinson’s disease patients disclose their adverse events spontaneously? Eur J Clin Pharmacol 68(5):857–865. doi:10.1007/s00228-011-1198-x
Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW (1997) II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94–1. J Pharmacol Exp Ther 282(2):1020–1027
Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson’s disease. Mov Disord 25(11):1660–1669. doi:10.1002/mds.23147
Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J (2003) Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 110(5):561–572. doi:10.1007/s00702-002-0805-5
Rogers RD (2011) The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology 36(1):114–132. doi:10.1038/npp.2010.165
Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR 4th, Benjamin J, Murphy DL, Hamer DH (1999) A genetic association for cigarette smoking behavior. Health Psychol 18(1):7–13
Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1997) Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41(3):299–304. pii:S0006322396000443
Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, Ono Y, Kanba S (2004) Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 29(2):134–137
Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M (2000) Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 57(7):666–673. doi:yoa9396
Stoltenberg SF, Vandever JM (2010) Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk. Neuropharmacology 58(2):423–428. doi:10.1016/j.neuropharm.2009.09.010
Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A (2012) Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders. Parkinsonism Relat Disord 18(4):397–399. doi:10.1016/j.parkreldis.2011.10.019
Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358(6382):149–152. doi:10.1038/358149a0
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14(4):1104–1106
Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997) High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74(4):439–442. doi:10.1002/(SICI)1096-8628(19970725)74:4<439:AID-AJMG16>3.0.CO;2-J
Volberg RA (1994) The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 84(2):237–241
Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69(6):986–996. doi:10.1002/ana.22356
Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595. doi:10.1001/archneurol.2010.65
Wilson D, da Silva Lobo DS, Tavares H, Gentil V, Vallada H (2012) Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci. doi:10.1007/s12031-012-9846-x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cormier, F., Muellner, J. & Corvol, JC. Genetics of impulse control disorders in Parkinson’s disease. J Neural Transm 120, 665–671 (2013). https://doi.org/10.1007/s00702-012-0934-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-012-0934-4